Skip to main content
. 2021 Aug 18;13(11):1249–1260. doi: 10.1002/pmrj.12668

TABLE 1.

Chronic conditions by type

Chronic condition/risk factor type a Description b N (%)
Neurological disorders Disorders of the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy (seizure disorders), stroke, intellectual disability, moderate to severe developmental delay, muscular dystrophy, or spinal cord injury 609 (23.7%)
Lung disease Asthma or chronic obstructive pulmonary disease (eg, chronic bronchitis or emphysema, or other chronic conditions associated with impaired lung function or that require home oxygen) 433 (16.8%)
Endocrine disorders For instance, diabetes mellitus 417 (16.2%)
Compromised immune system/immunosuppression Seeing a doctor for cancer and treatment such as chemotherapy or radiation, receiving an organ or bone marrow transplant, taking high doses of corticosteroids or other immunosuppressant medications, HIV or AIDS 403 (15.7%)
Heart disease Congenital heart disease, congestive heart failure, or coronary artery disease 234 (9.1%)
Blood disorders Sickle cell disease or on blood thinners 211 (8.2%)
Chronic kidney disease Patients who have been told to avoid or reduce the dose of medications due to kidney disease, or who are under treatment for kidney disease, including receiving dialysis 81 (3.1%)
Metabolic disorders Inherited metabolic disorders and mitochondrial disorders 55 (2.1%)
Chronic liver disease Cirrhosis, chronic hepatitis, or patients who have been told to avoid or reduce the dose of medications because of liver disease or are under treatment for liver disease 39 (1.5%)
a

Participants may endorse more than one one chronic condition. Due to this, the total number of conditions endorsed is greater than the sample size and the percentage does not equal 100%.

b

Descriptions of chronic conditions are based on CDC descriptions. 18